A compound called “6BIO” has been developed that can provide a better method to treat Autism Spectrum Disorder (ASD).
This is the first compound that has been proved in pre-clinical evaluation to have the potential for improving daily activities like learning and recollecting new tasks in patients with ASD/ Intellectual disability (ID).
